Unknown

Dataset Information

0

HT-SuMD: making molecular dynamics simulations suitable for fragment-based screening. A comparative study with NMR.


ABSTRACT: Fragment-based lead discovery (FBLD) is one of the most efficient methods to develop new drugs. We present here a new computational protocol called High-Throughput Supervised Molecular Dynamics (HT-SuMD), which makes it possible to automatically screen up to thousands of fragments, representing therefore a new valuable resource to prioritise fragments in FBLD campaigns. The protocol was applied to Bcl-XL, an oncological protein target involved in the regulation of apoptosis through protein-protein interactions. Initially, HT-SuMD performances were validated against a robust NMR-based screening, using the same set of 100 fragments. These independent results showed a remarkable agreement between the two methods. Then, a virtual screening on a larger library of additional 300 fragments was carried out and the best hits were validated by NMR. Remarkably, all the in silico selected fragments were confirmed as Bcl-XL binders. This represents, to date, the largest computational fragments screening entirely based on MD.

SUBMITTER: Ferrari F 

PROVIDER: S-EPMC7598995 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

HT-SuMD: making molecular dynamics simulations suitable for fragment-based screening. A comparative study with NMR.

Ferrari Francesca F   Bissaro Maicol M   Fabbian Simone S   De Almeida Roger Jessica J   Mammi Stefano S   Moro Stefano S   Bellanda Massimo M   Sturlese Mattia M  

Journal of enzyme inhibition and medicinal chemistry 20211201 1


Fragment-based lead discovery (FBLD) is one of the most efficient methods to develop new drugs. We present here a new computational protocol called High-Throughput Supervised Molecular Dynamics (HT-SuMD), which makes it possible to automatically screen up to thousands of fragments, representing therefore a new valuable resource to prioritise fragments in FBLD campaigns. The protocol was applied to Bcl-X<sub>L</sub>, an oncological protein target involved in the regulation of apoptosis through pr  ...[more]

Similar Datasets

| S-EPMC9706429 | biostudies-literature
| S-EPMC8250706 | biostudies-literature
| S-EPMC6017141 | biostudies-literature
| S-EPMC7683495 | biostudies-literature
| S-EPMC4183297 | biostudies-literature
| S-EPMC7057144 | biostudies-literature
| S-EPMC5176272 | biostudies-literature
| S-EPMC7317758 | biostudies-literature
| S-EPMC6651732 | biostudies-literature
| S-EPMC9630929 | biostudies-literature